Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRACE RA
2006-006032-22Phase 3Completed
- Sponsor
- The University of Manchester
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Atorvastatin + standard therapy with Placebo + standard therapy (2 arms). Primary endpoint: Co-primary cardiovascular outcomes. Started Feb 2007; status: completed.
02
Drugs
atorvastatin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-006032-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006032-22.